Vanguard Capital Management (CHE) reports 744,055 shares, 5.40% stake
Rhea-AI Filing Summary
Chemed Corp Schedule 13G: Vanguard Capital Management reports beneficial ownership of 744,055 shares of Common Stock, representing 5.40% of the class as of 03/31/2026. The filer reports sole voting power over 107,985 shares and sole dispositive power over 744,055 shares.
The filing is signed by Vanguard's Head of Global Fund Administration on 04/29/2026 and describes holdings that include securities held by Vanguard funds and managed accounts.
Positive
- None.
Negative
- None.
Insights
Vanguard holds a modest 5.40% stake in Chemed through managed funds and accounts.
Vanguard Capital Management reports beneficial ownership of 744,055 shares, with sole dispositive power over that entire amount and sole voting power over 107,985 shares. The Schedule 13G presentation indicates passive/long holdings rather than an active acquisition intent.
Timing anchors: ownership is reported as of 03/31/2026 and the form is signed 04/29/2026. Subsequent filings would show any changes in position.
The filing follows Schedule 13G disclosure norms for institutional investors exceeding 5%.
The statement includes the statutory disclosure that holdings reflect securities of Vanguard funds and managed accounts and notes no single third party holds >5% of the reported position. The form lists voting and dispositive power breakdowns as required.
Disclosure qualifiers are included verbatim in the filing; any material change would appear in an amended filing.